Fusion guided trans rectal ultrasound prostate biopsy.
Does targeted biopsy following multi parametric Magnetic Resonance Imaging (mpMRI) result in more accurate detection of significant prostate cancer.
Trevor Parker, Hull University Teaching Hospitals NHS Trust
Introduction
Prostate cancer is the second most common cancer in UK males, with over 47,000 men diagnosed annually . There is no completely reliable screening test for prostate cancer and diagnosis is complex, with some positive tests finding clinically insignificant cancer.
Development of multi-parametric MRI has made implementation of fusion guided biopsy possible, allowing specific targeting of sinister lesions seen at MRI, with evidence showing improved detection of clinically significant cancer across multiple studies.
Development of fusion technology enables CT and MRI images to be synchronised with real time ultrasound images, allowing real-time direct targeting of suspicious lesions within organs. Fusion imaging is established within our institution, but can it actually aid the detection of clinically significant prostate cancer? This poster outlines the single centre audit carried out in our institution.